These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 13213086)

  • 1. Paroxysmal flushing and other symptoms caused by 5-hydroxytryptamine and histamine in patients with malignant tumours.
    PERNOW B; WALDENSTROM J
    Lancet; 1954 Nov; 267(6845):951. PubMed ID: 13213086
    [No Abstract]   [Full Text] [Related]  

  • 2. Case of metastasizing carcinoma (argentaffinoma?) of unknown origin showing peculiar red flushing and increased amounts of histamine and 5-hydroxy-tryptamine in blood and urine.
    PERNOW B; SILWER H; WALDENSTROM J
    Acta Med Scand; 1956 Dec; 156(2):73-83. PubMed ID: 13381420
    [No Abstract]   [Full Text] [Related]  

  • 3. Histamine in carcinoid syndrome.
    Gustafsen J; Boesby S; Man WK
    Agents Actions; 1988 Aug; 25(1-2):1-3. PubMed ID: 3189038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of 5-hydroxytryptamine, 5-hydroxyindole acetic acid and histamine in thirty-three cases of carcinoid tumor (argentaffinoma).
    PERNOW B; WALDENSTROM J
    Am J Med; 1957 Jul; 23(1):16-25. PubMed ID: 13444287
    [No Abstract]   [Full Text] [Related]  

  • 5. Novel flushing provoked by volatile anesthetics in Mastomys natalensis bearing a transplantable substrain of gastric carcinoid that predominantly secretes serotonin.
    Hosoda S; Suyama M; Saito T; Kohmura Y; Hosoda R
    J Natl Cancer Inst; 1984 Jun; 72(6):1437-42. PubMed ID: 6202924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant carcinoid with hyperserotonemia occurring spontaneously or induced by palpation of the tumor or by intravenous histamine: report of a case.
    DAUGHERTY GW; MANGER WM; ROTH GM; FLOCK EV; CHILDS DS; WAUGH JM
    Proc Staff Meet Mayo Clin; 1955 Dec; 30(25):595-601. PubMed ID: 13273522
    [No Abstract]   [Full Text] [Related]  

  • 7. A beta-hydroxytryptophan-secreting carcinoid tumour.
    CAMPBELL AC; GOWENLOCK AH; PLATT DS; SNOW PJ
    Gut; 1963 Mar; 4(1):61-7. PubMed ID: 14018107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Carcinoid of the gastrointestinal system (study of a clinical case)].
    Terzi A; Deimichei R; Kuel AM; Amerio L; Robbiati SF; Bruseghini R; Bernardi A; Marchese GF; Insacco R; Salvelli S
    Chir Ital; 1984 Jun; 36(3):321-56. PubMed ID: 6151878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant carcinoid tumours.
    STACEY RS
    Proc R Soc Med; 1957 Jan; 50(1):40-3. PubMed ID: 13400852
    [No Abstract]   [Full Text] [Related]  

  • 10. Flushing Disorders Associated with Gastrointestinal Symptoms: Part 1, Neuroendocrine Tumors, Mast Cell Disorders and Hyperbasophila.
    Rastogi V; Singh D; Mazza JJ; Parajuli D; Yale SH
    Clin Med Res; 2018 Jun; 16(1-2):16-28. PubMed ID: 29650525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complications of midgut carcinoid tumors and carcinoid syndrome.
    van der Horst-Schrivers AN; Wymenga AN; Links TP; Willemse PH; Kema IP; de Vries EG
    Neuroendocrinology; 2004; 80 Suppl 1():28-32. PubMed ID: 15477713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical aspects and pathophysiology of carcinoid and carcinoid syndrome with special reference to the pharmacology of 5-hydroxytryptamine].
    KAEHLER HJ; HEILMEYER L
    Ergeb Inn Med Kinderheilkd; 1961; 16():292-559. PubMed ID: 13791247
    [No Abstract]   [Full Text] [Related]  

  • 13. Malignant carcinoid tumor altered reactivity of the skin to serotonin in two patients.
    ROTBART M
    Calif Med; 1958 Feb; 88(2):112-3. PubMed ID: 13500214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Demonstration of 5-hydroxytryptamine in the carcinoid of the small intestine described by Kahr].
    HORNYKIEWICZ O
    Acta Neuroveg (Wien); 1956; 13(1):110-1. PubMed ID: 13326324
    [No Abstract]   [Full Text] [Related]  

  • 15. Metastasizing carcinoid and 5-hydroxytryptamine.
    JENSEN K
    Dan Med Bull; 1957 May; 4(3):96-101. PubMed ID: 13437704
    [No Abstract]   [Full Text] [Related]  

  • 16. [Symptoms & diagnosis of malignant argentaffinoma (carcinoidosis)].
    WALDENSTROM J
    Brux Med; 1957 Aug; 37(32):1183-8. PubMed ID: 13460397
    [No Abstract]   [Full Text] [Related]  

  • 17. Skin manifestations in carcinoid syndrome. Serotonin-producing carcinoid tumour of the ileum with liver metastases and flushing of the skin. Report of a case with cutaneous symptoms only.
    WEREIDE K; NESET G
    Acta Derm Venereol; 1961; 41():264-76. PubMed ID: 13784412
    [No Abstract]   [Full Text] [Related]  

  • 18. Culture of neoplastic mast cells and their synthesis of 5-hydroxytryptamine and histamine in vitro.
    SCHINDLER R; DAY M; FISCHER GA
    Cancer Res; 1959 Jan; 19(1):47-51. PubMed ID: 13618883
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibitory effects of ranitidine on flushing and serum serotonin concentrations in carcinoid syndrome.
    Noppen M; Jacobs A; Van Belle S; Herregodts P; Somers G
    Br Med J (Clin Res Ed); 1988 Mar; 296(6623):682-3. PubMed ID: 3128368
    [No Abstract]   [Full Text] [Related]  

  • 20. [Carcinoid and hydroxytryptamine].
    RATZENHOFER M
    Krebsarzt; 1956 Oct; 11(5):257-75. PubMed ID: 13386198
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.